 | Rubius Therapeutics (NASDAQ:RUBY) Now Covered by Analysts at Robert W. Baird
www.americanbankingnews.com - September 9 at 8:39 PM |
| -$0.53 EPS Expected for Rubius Therapeutics Inc (NASDAQ:RUBY) This Quarter
www.americanbankingnews.com - September 8 at 4:23 AM |
| Rubius Therapeutics Inc (NASDAQ:RUBY) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 6 at 4:41 AM |
| JPMorgan Chase & Co. Lowers Rubius Therapeutics (NASDAQ:RUBY) Price Target to $22.00
www.americanbankingnews.com - August 29 at 8:56 AM |
 | Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress
finance.yahoo.com - August 13 at 9:12 AM |
| Rubius Therapeutics to Announce Second Quarter 2019 Financial Results
finance.yahoo.com - August 7 at 7:03 PM |
| Rubius Therapeutics Appoints Kris Elverum as Senior Vice President of Business Development and Strategy
finance.yahoo.com - July 25 at 2:06 PM |
| Investors Who Bought Rubius Therapeutics (NASDAQ:RUBY) Shares A Year Ago Are Now Down 44%
finance.yahoo.com - July 19 at 6:30 PM |
 | Rubius Therapeutics (RUBY) Presents At Jefferies 2019 Healthcare Conference - Slideshow
seekingalpha.com - June 7 at 4:01 PM |
| Rubius Therapeutics Announces Issuance of Multiple U.S. Patents for its Red Cell Therapeutic Programs
finance.yahoo.com - June 5 at 11:40 AM |
| Rubius Therapeutics to Present at Jefferies 2019 Healthcare Conference
finance.yahoo.com - May 29 at 11:29 AM |
| Rubius Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress
finance.yahoo.com - May 15 at 11:48 AM |
| Rubius Therapeutics Announces Extensive Preclinical Data for Three Red Cell Therapeutic Oncology Programs at the 2019 American Association for Cancer Research Annual Meeting
finance.yahoo.com - April 2 at 11:23 AM |
| Rubius Therapeutics Reports Fourth Quarter and Full-Year 2018 Financial Results with Business Updates
finance.yahoo.com - March 28 at 12:49 PM |
| How Many Insiders Bought Rubius Therapeutics, Inc. (NASDAQ:RUBY) Shares?
finance.yahoo.com - March 26 at 12:27 PM |
| Rubius Therapeutics Appoints Natalie Holles to its Board of Directors and Greg Whitehead as Senior Vice President and Chief Quality Officer
finance.yahoo.com - March 25 at 12:00 PM |
| Rubius Therapeutics to Announce Fourth Quarter and Full-Year 2018 Financial Results
finance.yahoo.com - March 20 at 11:42 AM |
 | Rubius Therapeutics, Inc. Estimate Momentum
www.nasdaq.com - March 18 at 3:59 PM |
| Rubius Therapeutics Announces FDA Clearance of Investigational New Drug Application for First-Ever Red Cell Therapeutic, RTX-134, for Treatment of Phenylketonuria
finance.yahoo.com - March 11 at 8:49 AM |
| Rubius Therapeutics Announces Poster Presentations at the 2019 American Association for Cancer Research Annual Meeting
finance.yahoo.com - February 28 at 12:25 PM |
| Rubius Therapeutics to Participate at Upcoming Investor Conferences
finance.yahoo.com - February 20 at 12:13 PM |
 | TCR2, Avedro wrangle $145M in first life science IPOs of 2019
www.bizjournals.com - February 14 at 3:39 PM |
| Rubius Therapeutics (RUBY) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 9 at 3:34 PM |
| Rubius Therapeutics Highlights Upcoming 2019 Milestones at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 7 at 10:59 AM |
| Biotechs dominate largest IPOs among Mass. companies in 2018
www.bizjournals.com - December 27 at 10:18 AM |
| Rubius Therapeutics, Inc. Secures $75 Million Loan Facility
finance.yahoo.com - December 21 at 3:27 PM |
 | Rubius Therapeutics Inc.
www.barrons.com - December 19 at 3:29 PM |
| Rubius Therapeutics Added to Nasdaq Biotechnology Index
finance.yahoo.com - December 18 at 9:53 AM |
| Qatar Fund Building Venture Capital Unit for U.S. Startups
finance.yahoo.com - December 16 at 9:30 AM |
| Flagship Pioneering Names Ryan Watts, CEO of Denali Therapeutics, as Recipient of the 2018 Pioneering Leader Award
www.bizjournals.com - November 15 at 3:22 PM |
| Rubius Therapeutics Reports Third Quarter 2018 Financial Results and Operational Progress
finance.yahoo.com - November 13 at 3:23 PM |
| Rubius Therapeutics to Participate in Jefferies London Healthcare Conference
finance.yahoo.com - November 7 at 8:11 AM |
| Rubius Therapeutics to Announce Third Quarter 2018 Financial Results
finance.yahoo.com - November 6 at 7:56 AM |
| Rubius (RUBY) in Focus: Stock Moves 8.7% Higher
finance.yahoo.com - September 24 at 3:18 PM |
| Biotech Market is Rolling and These Companies Need to Be on Your Radar
finance.yahoo.com - September 24 at 3:18 PM |
| Rubius Therapeutics to Participate in the Leerink Partners Roundtable Series: Rare Disease & Immuno-Oncology
finance.yahoo.com - September 21 at 6:54 AM |
| Rubius Therapeutics Added to Russell 2000 and 3000 Indexes
finance.yahoo.com - September 15 at 6:31 AM |
| How This Biotech IPO Is Facing Off Vs. BioMarin In Metabolic Disease
finance.yahoo.com - September 6 at 6:16 AM |
| What you missed on your summer vacation in Mass. biotech news
finance.yahoo.com - September 4 at 6:37 AM |
| Rubius Therapeutics reports Q2 results
seekingalpha.com - August 31 at 3:17 PM |
| Rubius Therapeutics to Announce Second Quarter 2018 Financial Results
finance.yahoo.com - August 22 at 6:06 AM |
 | Rubius Therapeutics Inc. (RUBY) Prices 10.48M Share IPO at $23/Sh
www.streetinsider.com - August 3 at 5:27 AM |
| Rubius Therapeutics (RUBY) Agrees to Acquire Manufacturing Facility in Smithfield, Rhode Island
www.streetinsider.com - July 30 at 3:15 PM |
| Rubius to acquire Rhode Island manufacturing site
seekingalpha.com - July 27 at 8:43 AM |
| Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics
finance.yahoo.com - July 27 at 8:43 AM |
